Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Evervita is a multivitamin and multimineral supplement developed and marketed by Blue Heron Pharmaceuticals. It is formulated as an oral tablet containing a comprehensive blend of essential micronutrients, including vitamins A, C, D3, E, and a full B-complex (thiamine, riboflavin, niacinamide, pyridoxine, folic acid, cyanocobalamin, biotin, and pantothenic acid), alongside key minerals such as calcium, iron, zinc, and magnesium. The product is intended to support overall nutritional health, prevent or treat vitamin and mineral deficiencies, and ensure adequate intake of essential nutrients in individuals with increased requirements or restricted diets. It is typically distributed as a prescription-grade or high-potency supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Evervita.